SRC-TR-POCUS-001 · Real secondary context
Hospital acute-care imaging context
Portable cardiac ultrasound may be considered across cardiology and acute-care settings where bedside assessment matters.
Demonstration sample · Türkiye
Portable AI-Enabled Cardiac Ultrasound System
Country: Türkiye. Use case: Hospital-based portable cardiac ultrasound used in relevant acute-care and cardiac-assessment settings.
DEMO-01
Product / Country / Adoption Decision
Product
Portable AI-Enabled Cardiac Ultrasound System
Country
Türkiye
Adoption decision
What clinical and institutional barriers must be solved before commercial introduction of this portable AI-enabled cardiac ultrasound system in Türkiye, and what conditions are required for adoption?
DEMO-02 · Real Türkiye context
Locked secondary context only.
These statements orient the adoption decision. They are real-secondary context labels for demonstration structure — not interview findings.
SRC-TR-GOV-001 · Real secondary context
Governance and accountability pressure
Institutional adoption depends on who may use the device, under what supervision, and who remains accountable for interpretation and documentation.
SRC-TR-IMP-001 · Real secondary context
Implementation and ownership conditions
Training load, device custody, IT/clinical engineering support, and budget ownership shape whether clinical interest can become institutional deployment.
DEMO-03
Who must be heard in Türkiye for this decision.
Cardiology / Cardiac Ultrasound
Clinical role, image quality expectations, and governance norms for cardiac assessment.
Emergency / ICU
Acute workflow fit, time pressure, and cross-department utility.
Implementation / Technical
Training, integration, device support, and operational feasibility.
Institutional / Economic
Sponsorship, budget ownership, procurement, and institutional conditions.
DEMO-04
Illustrative fieldwork design
Composition shows decision coverage across strata. It does not imply statistical representation or completed interviews.
ILLUSTRATIVE FIELDWORK DESIGN — NOT COMPLETED RESEARCH
- Cardiology / Cardiac Ultrasound5
- Emergency / ICU4
- Implementation / Technical3
- Institutional / Economic3
Total illustrative design: 15 synthetic participant slots. Not statistical representation.
DEMO-05
Clinical role
CAI-CL-01 · Clinical Role
Clinical role remains contested across acute-care settings
Synthetic primary-research demonstration suggests the portable system may be valued for bedside cardiac assessment, while role boundaries between cardiology and acute-care users remain unsettled.
Decision implication
Commercial introduction requires a defined clinical-role map before broad deployment claims.
Limitation. Illustrative only. Not derived from completed Turkish primary fieldwork.
Step 01
Identify clinical need at bedside
Step 02
Acquire portable cardiac images
Step 03
Interpret within role / governance rules
Step 04
Document and escalate as required
Step 05
Feed institutional learning / ownership
Identify clinical need at bedside → Acquire portable cardiac images → Interpret within role / governance rules → Document and escalate as required → Feed institutional learning / ownership
DEMO-06 · Signature visual
Clinical Access vs Clinical Governance
CAI-GOV-01 · Clinical Access vs Clinical Governance
Clinical access is not the same as clinical governance
Access interest from clinical users can coexist with unresolved governance: who may acquire images, who may interpret, and who remains accountable.
Decision implication
Adoption planning must separate permission to use from accountability for interpretation and documentation.
Limitation. Demonstration interpretation. No completed Turkish interviews underpin this sample.
Clinical access
Who can reach and operate the portable system in acute-care or cardiac-assessment settings.
Clinical governance
Who may interpret, who remains accountable, and which supervision rules apply.
Signature finding pattern (CAI-GOV-01): access interest can exist while governance remains unresolved.
DEMO-07
AI is not one question
CAI-AI-01 · AI Acquisition Assistance vs Interpretation Responsibility
AI acquisition assistance is not interpretation responsibility
Stakeholders may accept guidance for acquisition or image quality while rejecting automated clinical interpretation or automated reporting without clear accountability.
Decision implication
Position AI capabilities by responsibility boundary, not as a single “AI feature” claim.
Limitation. Framework for research discussion only — not a claim about the illustrative product’s actual functions.
AI CAPABILITY FRAMEWORK FOR RESEARCH — NOT A CLAIM ABOUT THE ILLUSTRATIVE PRODUCT
Level 01
Acquisition Guidance
Level 02
Image Quality Guidance
Level 03
Automated Measurement
Level 04
Clinical Interpretation
Level 05
Automated Reporting
DEMO-08
Clinical value vs implementation feasibility
CAI-IMP-01 · Clinical Value vs Implementation Feasibility
Clinical value can outpace implementation feasibility
Perceived bedside value does not automatically resolve training load, device support, or operational reliability conditions.
Decision implication
A launch plan must pair clinical value claims with explicit implementation conditions.
Limitation. Illustrative contradiction pattern for demonstration purposes only.
Clinical value signal
Bedside assessment utility may be recognized by clinical users.
Implementation feasibility
Training load, device support, and operational reliability may lag behind perceived value.
Finding pattern CAI-IMP-01: value and feasibility are plotted as separate axes — not averaged into a score.
DEMO-09
Cross-department value vs ownership
CAI-OWN-01 · Cross-Department Utility vs Institutional / Economic Ownership
Cross-department utility does not define institutional ownership
Potential utility across Cardiology, Emergency, and ICU leaves sponsor, budget owner, device owner, governance owner, and technical owner unresolved.
Decision implication
Ownership mapping is a prerequisite condition, not a post-launch detail.
Limitation. Ownership questions are shown unanswered by design. Do not invent owners.
Potential cross-department utility
- Cardiology
- Emergency
- ICU
Who owns the decision?
- Sponsor — ?
- Budget Owner — ?
- Device Owner — ?
- Governance Owner — ?
- Technical Owner — ?
Ownership answers are intentionally unresolved in this demonstration (CAI-OWN-01).
DEMO-10
Evidence conflict
Perspective A
Synthetic acute-care perspective (SYN-TR-ED-02): bedside cardiac assessment may be valued when time pressure is high.
Perspective B
Synthetic institutional perspective (SYN-TR-INST-01): sponsorship may stay withheld until governance, competency, and ownership are defined.
Training / governance bridge
Training and governance requirements sit between clinical enthusiasm and institutional permission.
Management question: Which conditions must be true before clinical interest can become institutional adoption?
DEMO-11
Adoption barrier preview
Barrier family 01
Clinical Governance
Who may use the system, under what supervision, and who is accountable for interpretation.
Barrier family 02
Training / Competency
What competency model is required before non-specialist or cross-department use is acceptable.
Barrier family 03
Technical Implementation
Device support, workflow integration, and operational reliability conditions.
Barrier family 04
Institutional Ownership / Procurement
Who sponsors, budgets, owns, and purchases the capability across departments.
Family 01
Clinical Governance
Who may use the system, under what supervision, and who is accountable for interpretation.
Family 02
Training / Competency
What competency model is required before non-specialist or cross-department use is acceptable.
Family 03
Technical Implementation
Device support, workflow integration, and operational reliability conditions.
Family 04
Institutional Ownership / Procurement
Who sponsors, budgets, owns, and purchases the capability across departments.
DEMO-12
Evidence trace for CAI-GOV-01
Trace step 01
Real secondary context
SRC-TR-GOV-001 situates accountability pressure around imaging use.
Trace step 02
Synthetic primary-research demonstration
SYN-TR-CARD-02 and SYN-TR-INST-01 illustrate conflicting access vs governance perspectives.
Trace step 03
GHMAP synthesis / interpretation
Access interest can coexist with unresolved interpretation accountability.
Trace step 04
Decision implication
Separate permission to use from accountability for interpretation and documentation.
Real secondary context
Locked Türkiye secondary context for orientation only.
Synthetic primary-research demonstration
Explicitly synthetic participant-derived examples. IDs begin with SYN-.
GHMAP synthesis / interpretation
Decision-relevant patterns without averaging contradictions.
Decision implication
Conditions, barriers, or insufficient evidence stated with limitations.
DEMO-13
Evidence gap
CAI-DATA-01 · Evidence Gap — Integration
Integration pathway remains insufficiently evidenced
Available demonstration materials do not establish a concrete hospital IT / clinical-engineering integration pathway for this illustrative product in Türkiye.
Decision implication
Treat integration as UNKNOWN and validate next before any adoption conclusion that depends on it.
Limitation. INSUFFICIENT EVIDENCE example only — not an established Türkiye integration barrier finding.
Known
Governance and ownership questions are decision-relevant for this use case.
Unknown
Concrete hospital IT / clinical-engineering integration pathway for the illustrative product.
Validate next
Confirm integration conditions before any adoption conclusion that depends on them.
Known
Clinical access vs governance and ownership questions are decision-relevant for this use case.
Unknown
Concrete hospital IT / clinical-engineering integration pathway for the illustrative product (CAI-DATA-01).
Validate next
Confirm integration, ownership, and competency conditions before any adoption conclusion that depends on them.
DEMO-14
Illustrative decision output
Illustrative decision output — not a conclusion from completed primary research
NO MATERIAL ADOPTION BARRIER IDENTIFIED WITHIN RESEARCH SCOPE
ADOPTION REQUIRES DEFINED CONDITIONS
Structurally highlighted for demonstration only
MATERIAL ADOPTION BARRIERS IDENTIFIED
EVIDENCE INSUFFICIENT FOR ADOPTION CONCLUSION
Limitation. Structurally highlighting “ADOPTION REQUIRES DEFINED CONDITIONS” does not mean completed Turkish primary research reached that conclusion.
DEMO-15
Client outputs, report preview, and workbook preview
Output 01
Executive Adoption Decision Summary
A management-facing statement of barriers, conditions, disagreement, and remaining uncertainty.
Output 02
Clinical Adoption Intelligence Report
Decision-structured findings with evidence layers, contradictions, and implications.
Output 03
Research Evidence Workbook
Traceable finding rows linking evidence layer, theme, implication, and limitation.
Output 04
Executive Debrief
A working review of what the evidence supports, what it does not, and what to validate next.
Report preview
Executive Adoption Decision Summary preview
Illustrative structure only: adoption conditions concentrate around governance, competency, implementation feasibility, and unresolved ownership across Cardiology, Emergency, and ICU.
CAI-GOV-01 · Clinical Access vs Clinical Governance
Clinical access is not the same as clinical governance
Access interest from clinical users can coexist with unresolved governance: who may acquire images, who may interpret, and who remains accountable.
Contradiction preview
Clinical enthusiasm and institutional withholding can coexist until training, governance, and ownership conditions are defined.
Evidence Trace / methodology preview
Real secondary → synthetic primary demonstration → GHMAP interpretation → decision implication, with limitations stated at each step.
Workbook preview · curated rows
| Finding ID | Finding | Evidence Layer | Theme | Decision Implication | Limitation |
|---|---|---|---|---|---|
CAI-GOV-01 | Clinical access is not the same as clinical governance | GHMAP INTERPRETATION | Clinical Access vs Clinical Governance | Separate permission to use from accountability for interpretation. | Demonstration interpretation — not completed primary research. |
CAI-AI-01 | AI acquisition assistance is not interpretation responsibility | GHMAP INTERPRETATION | AI Capability Boundaries | Position AI by responsibility boundary, not as one claim. | Research framework only — not a product capability claim. |
CAI-IMP-01 | Clinical value can outpace implementation feasibility | GHMAP INTERPRETATION | Clinical Value vs Implementation | Pair value claims with explicit implementation conditions. | Illustrative contradiction pattern. |
CAI-DATA-01 | Integration pathway remains insufficiently evidenced | INSUFFICIENT EVIDENCE | Evidence Gap | Validate integration before conclusions that depend on it. | Insufficient-evidence example — not an established barrier. |
Full internal workbook tabs are not exposed publicly.
Next step
Request a Proposal
One product. One country. One clinical use case. One adoption decision.
No public pricing.